|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. New Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grossman SA, Ye X, Piantadosi S, Desideri
S, Nabors LB, Rosenfeld M and Fisher J; NABTT CNS Consortium, :
Survival of patients with newly diagnosed glioblastoma treated with
radiation and temozolomide in research studies in the United
States. Clin Cancer Res. 16:2443–2449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang
Z, Dai Z, Zhang X, Zhang L, Peng Y, et al: Glioma targeted therapy:
Insight into future of molecular approaches. Mol Cancer. 21:392022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
WHO Classification of Tumours Editorial
Board, . World Health Organization Classification of Tumours of the
Central Nervous System. 5th Edition. International Agency for
Research on Cancer; Lyon: 2021
|
|
5
|
Mettler FA Jr, Thomadsen BR, Bhargavan M,
Gilley DB, Gray JE, Lipoti JA, McCrohan J, Yoshizumi TT and Mahesh
M: Medical radiation exposure in the US in 2006: Preliminary
results. Health Phys. 95:502–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Le Bihan D, Breton E, Lallemand D, Grenier
P, Cabanis E and Laval-Jeantet M: MR imaging of intravoxel
incoherent motions: Application to diffusion and perfusion in
neurologic disorders. Radiology. 161:401–407. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Upadhyay N and Waldman A: Conventional MRI
evaluation of gliomas. Brit J Radiol. 84((Spec Iss 2)): S107–S111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu S, Guan J and Liu Y: Identification of
microRNAs as novel biomarkers for glioma detection: A meta-analysis
based on 11 articles. J Neurol Sci. 348:181–187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loke SY and Lee ASG: The future of
blood-based biomarkers for the early detection of breast cancer.
Eur J Cancer. 92:54–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duffy MJ and O'Byrne K: Tissue and blood
biomarkers in lung cancer: A review. Adv Clin Chem. 86:1–21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang ZL, Zhang CB, Liu YQ, Wang Z and
Jiang T: Peripheral blood test provides a practical method for
glioma evaluation and prognosis prediction. CNS Neurosci Ther.
25:876–883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weng W, Chen X, Gong S, Guo L and Zhang X:
Preoperative neutrophil-lymphocyte ratio correlated with glioma
grading and glioblastoma survival. Neurol Res. 40:917–922. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan P, Li JW, Mo LG and Huang QR: A
nomogram combining inflammatory markers and clinical factors
predicts survival in patients with diffuse glioma. Medicine
(Baltimore). 100:e279722021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharma G, Jain SK and Sinha VD: Peripheral
inflammatory blood markers in diagnosis of glioma and IDH status. J
Neurosci Rural Pract. 12:88–94. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng Q, He B, Liu X, Yue J, Ying H, Pan Y,
Sun H, Chen J, Wang F, Gao T, et al: Prognostic value of
pre-operative inflammatory response biomarkers in gastric cancer
patients and the construction of a predictive model. J Transl Med.
13:662015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Afari ME and Bhat T: Neutrophil to
lymphocyte ratio (NLR) and cardiovascular diseases: An update.
Expert Rev Cardiovasc Ther. 14:573–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang
J, Wang T, Zhu W and Liu P: Prognostic value of PLR in various
cancers: A meta-analysis. PLoS One. 9:e1011192014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han S, Huang Y, Li Z, Hou H and Wu A: The
prognostic role of preoperative serum albumin levels in
glioblastoma patients. BMC Cancer. 15:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eckart A, Struja T, Kutz A, Baumgartner A,
Baumgartner T, Zurfluh S, Neeser O, Huber A, Stanga Z, Mueller B
and Schuetz P: Relationship of nutritional status, inflammation,
and serum albumin levels during acute illness: A prospective study.
Am J Med. 133:713–722.e7. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ludwig H, Van Belle S, Barrett-Lee P,
Birgegård G, Bokemeyer C, Gascón P, Kosmidis P, Krzakowski M,
Nortier J, Olmi P, et al: The European Cancer Anaemia Survey
(ECAS): A large, multinational, prospective survey defining the
prevalence, incidence, and treatment of anaemia in cancer patients.
Eur J Cancer. 40:2293–2306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Colloca G, Venturino A, Vitucci P and
Gianni W: Management of anaemia in prostate cancer. Cancer Invest.
28:280–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mercadante S, Gebbia V, Marrazzo A and
Filosto S: Anaemia in cancer: Pathophysiology and treatment. Cancer
Treat Rev. 26:303–311. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng SH, Huang JL, Chen M, Wang BL, Ou QS
and Huang SY: Diagnostic value of preoperative inflammatory markers
in patients with glioma: A multicenter cohort study. J Neurosurg.
129:583–592. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li B, Gao B, Zhu HJ, Luwor RB, Lu J, Zhang
L and Kong B: The prognostic value of preoperative inflammatory
markers for pathological grading of glioma patients. Technol Cancer
Res Treat. 23:153303382412731602024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stepanenko AA, Sosnovtseva AO, Valikhov
MP, Chernysheva AA, Abramova OV, Pavlov KA and Chekhonin VP:
Systemic and local immunosuppression in glioblastoma and its
prognostic significance. Front Immunol. 15:13267532024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang J, Piao Y, Holmes L, Fuller GN,
Henry V, Tiao N and de Groot JF: Neutrophils promote the malignant
glioma phenotype through S100A4. Clin Cancer Res. 20:187–198. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Turner MC, Radzikowska U, Ferastraoaru DE,
Pascal M, Wesseling P, McCraw A, Backes C, Bax HJ, Bergmann C,
Bianchini R, et al: AllergoOncology: Biomarkers and refined
classification for research in the allergy and glioma nexus-A joint
EAACI-EANO position paper. Allergy. 79:1419–1439. 2024. View Article : Google Scholar : PubMed/NCBI
|
